Exon-skipping advances for Duchenne muscular dystrophy

Human Molecular Genetics
Lucía EchevarríaAurélie Goyenvalle

Abstract

Duchenne muscular dystrophy (DMD) is a fatal genetic disorder characterized by progressive muscle wasting that has currently no cure. Exon-skipping strategy represents one of the most promising therapeutic approaches that aim to restore expression of a shorter but functional dystrophin protein. The antisense field has remarkably progress over the last years with recent accelerated approval of the first antisense oligonucleotide-based therapy for DMD, Exondys 51, though the therapeutic benefit remains to be proved in patients. Despite clinical advances, the poor effective delivery to target all muscle remains the main hurdle for antisense drug therapy. This review describes the antisense-based exon-skipping approach for DMD, from proof-of-concept to first marketed drug. We discuss the main obstacles to achieve a successful exon-skipping therapy and the latest advances of the international community to develop more powerful chemistries and more sophisticated delivery systems in order to increase potency, bioavailability and safety. Finally, we highlight the importance of collaborative efforts and early dialogue between drug developers and regulatory agencies in order to overcome difficulties, find appropriate outcome markers and ...Continue Reading

References

Apr 1, 1989·Anesthesia and Analgesia·T N Harwood, S S Moorthy
Aug 17, 1999·The Journal of Clinical Investigation·E R Barton-DavisH L Sweeney
Nov 6, 2004·Science·Aurélie GoyenvalleOlivier Danos
Dec 8, 2004·Nature Biotechnology·Sudhir Agrawal, Ekambar R Kandimalla
Feb 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michela Alessandra DentiIrene Bozzoni
Jun 21, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sue FletcherStephen D Wilton
Oct 31, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Haifang YinMatthew Wood
Dec 28, 2007·The New England Journal of Medicine·Judith C van DeutekomGert-Jan B van Ommen
Jun 19, 2008·Nucleic Acids Research·Rudy JulianoHyumin Kang
Jan 22, 2009·Human Mutation·Annemieke Aartsma-RusJohan T den Dunnen
Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola RimessiAlessandra Ferlini
Jun 3, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Akinori Nakamura, Shin'ichi Takeda
Dec 1, 2009·Lancet Neurology·Katharine BushbyUNKNOWN DMD Care Considerations Working Group
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·C Frank Bennett, Eric E Swayze
Feb 23, 2010·Biochimica Et Biophysica Acta·Hong M Moulton, Jon D Moulton
Jun 3, 2010·Annals of Neurology·Vinod MalikJerry R Mendell
Mar 25, 2011·The New England Journal of Medicine·Nathalie M GoemansJudith C van Deutekom
Apr 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·HaiFang YinMatthew Ja Wood
Feb 23, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aurélie GoyenvalleKay E Davies
Sep 13, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adeline VulinLuis Garcia
Apr 9, 2013·The FEBS Journal·Deborah Briggs, Jennifer E Morgan
Jun 12, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maëva Le HirStéphanie Lorain
Aug 3, 2013·Annals of Neurology·Jerry R MendellUNKNOWN Eteplirsen Study Group
Apr 16, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xianjun GaoHaiFang Yin
Sep 10, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Caroline Le GuinerThomas Voit
Mar 12, 2015·Scientific Reports·Corinne A BettsMatthew J A Wood
May 12, 2015·Frontiers in Bioscience (Landmark Edition)·Rachid BenchaouirAurelie Goyenvalle
Jul 3, 2015·Therapeutic Advances in Neurological Disorders·Dorota SienkiewiczKatarzyna Kawnik
Nov 18, 2015·Annals of Neurology·Jerry R MendellUNKNOWN Eteplirsen Study Group and Telethon Foundation DMD Italian Network
Jan 13, 2016·Journal of Medical Genetics·Annemieke Aartsma-RusKate Bushby
Apr 17, 2016·Nucleic Acids Research·Rudolph L Juliano
Aug 16, 2016·Neuropsychiatric Disease and Treatment·Jean K Mah

❮ Previous
Next ❯

Citations

Aug 23, 2018·Human Gene Therapy·Francesco GalliGiulio Cossu
Dec 18, 2018·Transcription·Emma R HinkleJimena Giudice
Sep 12, 2019·Arquivos de neuro-psiquiatria·Lineu Cesar WerneckRosana Herminia Scola
Dec 7, 2018·Biological & Pharmaceutical Bulletin·Yuya Hayashi, Hirofumi Jono
Mar 11, 2020·Pharmaceuticals·Danah Al ShaerBeatriz G de la Torre
Apr 4, 2020·The International Journal of Neuroscience·Arash SalmaninejadMajid Mojarrad
Apr 14, 2020·Expert Opinion on Drug Delivery·Shahin AghamiriHossein Ghanbarian
Aug 25, 2019·International Journal of Molecular Sciences·Tatyana A Meyers, DeWayne Townsend
Mar 8, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wayne W Grody
Jan 27, 2020·Journal of Muscle Research and Cell Motility·Michaela Yuen, Coen A C Ottenheijm
Sep 10, 2020·Biomedicines·Fanny JaudonLorenzo A Cingolani
Oct 20, 2020·Frontiers in Neuroscience·Raygene Martier, Pavlina Konstantinova
Jan 10, 2021·Journal of Applied Genetics·Janusz G ZimowskiJacek Zaremba
May 29, 2020·Molecular Therapy. Methods & Clinical Development·Philippine AupyAurélie Goyenvalle
Feb 11, 2021·European Journal of Human Genetics : EJHG·Vratko Himič, Kay E Davies
Dec 20, 2020·International Journal of Molecular Sciences·Wei ChiuHao-Min Cheng
Feb 4, 2021·Gene Therapy·Christian KupattMaggie C Walter
Dec 31, 2020·Neurology. Genetics·Rita SelvaticiAlessandra Ferlini
Nov 25, 2020·Molecular Therapy. Nucleic Acids·Kasturi SenguptaTejvir S Khurana
Mar 6, 2021·Orphanet Journal of Rare Diseases·Stephanie KourakisEmma Rybalka
Feb 26, 2021·Proceedings of the National Academy of Sciences of the United States of America·Rebecca A EllwoodNathaniel J Szewczyk
Apr 8, 2021·Cellular and Molecular Life Sciences : CMLS·Alicja Starosta, Patryk Konieczny
Apr 25, 2021·Seminars in Pediatric Neurology·Samuel J MackenzieJerry R Mendell
Jun 21, 2021·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·L ShenC A Pacak

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Cell
Courtney S Young, April D Pyle
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Juan Yang, Cheng Zhang
Drug Design, Development and Therapy
Kenji Rowel Q LimToshifumi Yokota
© 2022 Meta ULC. All rights reserved